Determination of antibodies directed at EBV proteins expressed in both latent and lytic cycles in nasopharyngeal carcinoma
- 1 April 2013
- journal article
- Published by Elsevier BV in Oral Oncology
- Vol. 49 (4), 326-331
- https://doi.org/10.1016/j.oraloncology.2012.10.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nasopharyngeal carcinomaAnnals of Oncology, 2010
- Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experienceInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Molecular Diversity of Epstein?Barr Virus IgG and IgA Antibody Responses in Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese, and European SubjectsThe Journal of Infectious Diseases, 2004
- Phase III Study of Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Advanced Nasopharyngeal Carcinoma: Positive Effect on Overall and Progression-Free SurvivalJournal of Clinical Oncology, 2003
- Epidemiology of nasopharyngeal carcinomaSeminars in Cancer Biology, 2002
- Serologic Markers of Epstein–Barr Virus Infection and Nasopharyngeal Carcinoma in Taiwanese MenThe New England Journal of Medicine, 2001
- Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2000
- ELISA for the detection of serum and saliva IgA against the BMRFI gene product of Epstein-Barr virusJournal of Medical Virology, 1996
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: Antibodies to EBV associated Membrane and Viral Capsid Antigens in Burkitt Lymphoma PatientsNature, 1970